Roche

By  Jonah Comstock 10:28 am September 30, 2015
Voluntis's Diabeo app, not available in the United States French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer. Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
By  Jonah Comstock 11:40 am August 13, 2015
Roche Pharma Research and Early Development, a division of Roche Pharmaceuticals, has developed a new mobile app to measure Parkinson's disease symptoms. The app was developed in partnership with Max Little, a British mathametician at the head of the Parkinson's Voice Initiative, and it will actually be used in a drug development trial with Prothena Biosciences. “The app is being used in a Phase...
By  Jonah Comstock 11:28 am July 8, 2015
Last month, Roche quietly launched its Accu-Chek Connect app, a diabetes management app which contains, among other things, an unprecented feature: a prescription insulin bolus calculator called Bolus Advisor. Roche has been selling the app in other countries for a little while, even issuing a brief recall in April in some of those countries. It received FDA clearance for the Android version of...
By  Jonah Comstock 08:56 am April 9, 2015
In March, Roche received FDA clearance for its Accu-Chek Connect companion app, and, less than a month later, issued a recall of that app. App recalls, which are becoming more common as more and more apps receive FDA clearance, are less severe than device recalls because they can often be ameliorated with a quick software patch. The app, available only on Android at present, helps patients track...
By  Jonah Comstock 11:07 am March 25, 2015
Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA clearance for their platform, which includes an app and a provider dashboard. They will also soon launch a major clinical trial in partnership with the Scripps Translational Science Institute and Roche, according to the...
By  Jonah Comstock 07:44 am January 29, 2015
Less than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life's 2net platform to capture patient data from connected devices, starting with anti-coagulation meters. “This collaboration marks a significant milestone for Roche as we launch a new generation of point-of-care...
By  Jonah Comstock 06:29 am October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...
By  Jonah Comstock 05:24 am September 23, 2014
Roche subsidiary Genentech is no stranger to online patient communities -- the pharma company signed a five-year data access deal with online patient community company PatientsLikeMe in April. At the Health 2.0 conference in Santa Clara this week, Genentech product development leader Joling Mew spoke about the ways that Genentech has worked with PatientsLikeMe, and other online patient...
By  Jonah Comstock 10:20 am April 28, 2014
Voluntis's app (not shown here) was one of the first to work with Sanofi's IBGStar connected glucometer. Paris, France-based Voluntis, a developer of companion apps for medical devices, has raised $29 million in its fourth round of funding. The round was led by Bpifrance Large Venture and international venture capital firm Innovation Capital. Other contributors included Luxemburg-based...
By  Jonah Comstock 08:11 am April 10, 2014
Boston-based PatientsLikeMe, a hub for crowd-sourced patient data and an open research platform, has announced its most wide-reaching pharma partnership yet, a five-year agreement to share data with Genentech, a division of Roche. "They are a forward-looking company in the health IT space, and ... I think they're really looking at new forms of evidence and how that can improve their business and...